Protirelin

Protirelinum

For medical students2 min readUpdated 2026-10-10

Protirelin (Protirelinum) is a synthetic peptide drug that structurally and pharmacologically mimics natural thyrotropin-releasing hormone (TRH). In modern medical practice, it is used exclusively for diagnostic purposes to evaluate anterior pituitary reserve and responsiveness.

StructureSynthetic tripeptide, exact functional analogue of thyrotropin-releasing hormone (TRH).

TargetAnterior pituitary gland (stimulation of TSH and prolactin release).

Peak ActionPeak TSH plasma concentration is reached 20–30 minutes after IV administration.

Clinical UseDifferential diagnosis of hypothyroidism and hyperthyroidism.

Mechanism of Action (Pharmacodynamics)

Protirelin is a synthetic tripeptide. Despite its relatively simple chemical structure, it exhibits high biological activity. Its primary target in the human body is the adenohypophysis (anterior pituitary).

Upon entering the systemic circulation, the drug binds to specific G-protein coupled receptors on the membranes of pituitary thyrotroph and lactotroph cells, triggering a signaling cascade that leads to two key pharmacodynamic effects:

Potent stimulation of thyroid-stimulating hormone (TSH) secretion, which normally acts on the thyroid gland to stimulate hormone synthesis and release.
Simultaneous stimulation of prolactin release.

This ability to precisely and predictably activate pituitary cells makes protirelin an essential tool for assessing the functional reserve of the endocrine axis.

Pharmacokinetics

Because the drug is used for acute diagnostic testing, it is administered exclusively via intravenous injection. This route ensures the immediate delivery of the active substance to the bloodstream and a rapid pituitary response.

Protirelin pharmacokinetics are characterized by a rapid onset and short duration:

Peak Concentration: The maximum plasma TSH surge is recorded 20–30 minutes following intravenous injection.
Duration of Effect: Hormone levels do not remain elevated for long; values return to baseline within 2–3 hours.

This short half-life and rapid clearance are ideal for diagnostics, allowing the test to be completed within a single clinic visit without causing prolonged disruption to the patient's hormonal balance.

Clinical Use and Testing Protocol

The primary indication for protirelin is the differential diagnosis of thyroid disorders. The drug acts as a provocative agent, helping clinicians pinpoint the anatomical level of endocrine dysfunction: whether the defect originates in the pituitary gland or the thyroid gland itself.

This diagnostic test helps identify and differentiate:

Primary hypothyroidism (pathology originating in the thyroid gland).
Secondary hypothyroidism (pathology caused by impaired adenohypophyseal function).
Subclinical (latent) hypothyroidism, which lacks prominent clinical symptoms.
Hyperthyroidism (excessive thyroid activity).

Standard Test Protocol:

A baseline blood sample is drawn from the resting patient to measure basal TSH and thyroid hormone levels.
An intravenous injection of protirelin is administered.
Exactly 30 minutes later (at the expected peak of action), a repeat blood sample is drawn.
The clinician evaluates the magnitude of the TSH response to differentiate the site of pathology.

Adverse Reactions

Administering a synthetic releasing hormone places acute stress on the autonomic nervous system, which can trigger several side effects. Typically, these reactions develop rapidly and are transient in nature.

Common adverse effects of protirelin include:

Nervous System: Headache, sudden episodes of anxiety.
Cardiovascular System: Blood pressure fluctuations, a transient sensation of chest tightness, and facial flushing (cutaneous hyperemia).
Other Reactions: Diaphoresis, mild hypersensitivity reactions, and local pain at the injection site.

Mnemonic

To remember protirelin effects, use the name: PRO-THY-relin. It stimulates PROlactin and THYroid-stimulating hormone (TSH). Timing follows the "rule of threes": peak response at 30 minutes, resolution within 3 hours.

Frequently asked questions

What pharmacological group does protirelin belong to?

Protirelin belongs to the class of releasing hormones, acting as a synthetic analogue of thyrotropin-releasing hormone. Structurally, it is a tripeptide hypothalamic hormone that stimulates anterior pituitary secretion.

Protirelin (Protirelinum) — synthetic TSH analogue, tripeptide.
Thyroliberin (TRH) — hypothalamic releasing hormone stimulating adenohypophyseal hormone synthesis and release.

How does the TSH response to protirelin change in primary hypothyroidism?

In primary hypothyroidism, basal TSH is elevated, and the response to protirelin is typically exaggerated. In borderline cases with normal T4 and borderline TSH, an augmented response helps confirm early primary hypothyroidism.

What chemical class does protirelin belong to?

Structurally, it is a synthetic tripeptide that serves as an exact analogue of natural hypothalamic thyrotropin-releasing hormone (TRH).

Which hormones are released by the pituitary gland in response to the drug?

The drug stimulates the secretion of two anterior pituitary hormones: thyroid-stimulating hormone (TSH) and prolactin.

What is the core principle of the protirelin stimulation test?

The test measures baseline TSH levels and compares them to levels measured 30 minutes post-injection. The resulting delta helps distinguish primary thyroid failure from secondary (pituitary) hypothyroidism.

What side effects commonly cause concern during administration?

Patients may experience a sudden sensation of chest tightness, anxiety, blood pressure fluctuations, and facial flushing. These symptoms resolve rapidly.

Go deeper

Feedback mechanisms in the hypothalamic-pituitary-thyroid (HPT) axis.
Distinguishing primary, secondary, and subclinical hypothyroidism using stimulation test results.
The physiological significance of parallel TSH and prolactin release.
Interpretation of plasma thyroid hormone panels.